Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 685,726 |
|
|||||
| News | (3) | ||||||
| Day High | 7.00 | Low High |
|||||
| Day Low | 6.48 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Fulcrum Therapeutics Inc | FULC | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.51 | -7.29% | 6.49 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 7.00 | 6.48 | 7.00 | 6.49 | 7.00 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,689 | 685,726 | US$ 6.68 | US$ 4,583,421 | - | 2.95 - 13.70 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:51:26 | 4 | US$ 6.45 | USD |
Fulcrum Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 401.34M | 61.94M | - | 2.81M | -97.34M | -1.57 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Fulcrum Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FULC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.04 | 8.31 | 6.48 | 7.44 | 742,476 | -1.55 | -19.28% |
| 1 Month | 7.61 | 8.69 | 6.48 | 7.74 | 539,109 | -1.12 | -14.72% |
| 3 Months | 9.46 | 9.81 | 6.48 | 7.84 | 519,426 | -2.97 | -31.40% |
| 6 Months | 5.49 | 13.70 | 5.26 | 8.40 | 617,957 | 1.00 | 18.21% |
| 1 Year | 3.00 | 13.70 | 2.95 | 6.00 | 990,792 | 3.49 | 116.33% |
| 3 Years | 8.39 | 33.0975 | 2.25 | 11.29 | 1,023,544 | -1.90 | -22.65% |
| 5 Years | 14.50 | 33.0975 | 2.25 | 11.32 | 666,514 | -8.01 | -55.24% |
Fulcrum Therapeutics Description
| Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. It has developed a proprietary product engine that employs to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairments and disability. |
